Dec. 29, 2025—Diasorin has received FDA 510(k) clearance and CLIA waiver for its first assay, the Flu A/B, RSV and COVID-19 panel, to be used on the Liaison Nes point-of-care molecular diagnostic platform. Features of the Liaison Nes include an integrated barcode reader, wireless operation, ready-to-use cartridges, and room-temperature consumables. Results are available in about 15 minutes.
Webinars and Sponsored Roundtables — Register Now
Wednesday, July 29, 2026, 1:00-2:00 PM ET
Learn about digital pathology technology that is future-ready, yet practical for today’s
laboratory needs.
Webinar presenters Scott Hammond, Senior Systems Consultant, Digital Pathology Division, Wexner Medical Center, Department of Pathology, and Ursula Hofer, Imaging Technologist, Pathology Digital Imaging Lab, Wexner Medical Center, Department of Pathology, and Sandra Banky, PA(ASCP), Director of Operations, Wexner Medical Center, Department of Pathology.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY